DAVIS SELECTED ADVISERS - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
DAVIS SELECTED ADVISERS ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2022$2,200,000
-10.1%
28,9430.0%0.02%0.0%
Q2 2022$2,447,000
-14.6%
28,943
-11.4%
0.02%
+14.3%
Q1 2022$2,866,000
-23.9%
32,656
-24.1%
0.01%
-17.6%
Q4 2021$3,764,000
+2.4%
43,035
-4.3%
0.02%0.0%
Q3 2021$3,677,000
-14.0%
44,968
-4.1%
0.02%
-5.6%
Q2 2021$4,278,000
+12.7%
46,888
+5.5%
0.02%
+5.9%
Q1 2021$3,797,000
-2.5%
44,424
+7.7%
0.02%
-10.5%
Q4 2020$3,896,000
+15.3%
41,256
+6.2%
0.02%0.0%
Q3 2020$3,378,000
+1.8%
38,848
+2.3%
0.02%0.0%
Q2 2020$3,318,000
+44.6%
37,988
+36.5%
0.02%
+18.8%
Q1 2020$2,295,000
-7.2%
27,840
+6.6%
0.02%
+33.3%
Q4 2019$2,473,000
+18.3%
26,120
+8.6%
0.01%
+9.1%
Q3 2019$2,090,000
-0.6%
24,056
+4.5%
0.01%
+10.0%
Q2 2019$2,102,000
+2.6%
23,024
+8.1%
0.01%0.0%
Q1 2019$2,048,000
+54.4%
21,304
+37.8%
0.01%
+42.9%
Q4 2018$1,326,000
-90.2%
15,456
-90.2%
0.01%
-87.9%
Q3 2018$13,576,000
+5.2%
157,573
-7.8%
0.06%
+5.5%
Q2 2018$12,903,000
-22.3%
170,811
-16.9%
0.06%
-23.6%
Q1 2018$16,611,000
-38.0%
205,456
-35.6%
0.07%
-36.8%
Q4 2017$26,799,000
-10.9%
319,186
-8.9%
0.11%
-10.9%
Q3 2017$30,063,000
+2.1%
350,186
-0.7%
0.13%
-0.8%
Q2 2017$29,450,000
+32.7%
352,820
+18.1%
0.13%
+34.4%
Q1 2017$22,185,000
+18.2%
298,710
+15.9%
0.10%
+17.1%
Q4 2016$18,769,000
+701.8%
257,670
+678.5%
0.08%
+1266.7%
Q2 2013$2,341,00033,1000.01%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders